{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:21:39Z","timestamp":1778278899447,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris-Saclay","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Sickle-cell disease (SCD) is a severe autosomal recessive disorder. At-risk couples may prevent transmission either through prenatal diagnosis with possible termination of pregnancy or preimplantation genetic testing for monogenic disease (PGT-M). Data on PGT-M outcomes in this population remain scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a monocentric retrospective study (2006\u20132021). To assess ovarian response to stimulation, each PGT-M cycle for SCD was matched with two control cycles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty couples underwent at least one ovarian stimulation for PGT procedure for SCD. Eight couples (13.3%) had one affected partner (S\/S or S\/C) and one carrier (A\/S), while 52 couples (86.7%) were both carriers (A\/S). Thirty-five couples (58.3%) already had an affected child, and 17 couples (28.3%) requested PGT-M with HLA typing. Median female age at first attempt was 33\u00a0years. Overall, 19 couples (31.7%) achieved at least one live birth following fresh or frozen embryo transfer. Among the 17 couples requesting HLA typing, three HLA-matched births (15.7%) and one unmatched healthy birth were achieved. None of the five women affected by SCD achieved a live birth. Ovarian response did not differ significantly between women with sickle cell trait and the controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PGT-M is as a viable option for obtaining healthy offspring. These results bolster the argument that PGT-M serves as an alternative to prenatal diagnosis for eligible couples. Our study aims to assist geneticists, gynecologists, and hematologists in providing the necessary guidance before embarking couples on this long and often challenging journey.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10815-026-03809-1","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:02:48Z","timestamp":1770282168000},"page":"1233-1242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of preimplantation genetic testing in sickle cell disease: insights from a single-center experience"],"prefix":"10.1007","volume":"43","author":[{"given":"A.","family":"Aganahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Souare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mayeur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Monnot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Benachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Frydman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Grynberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Steffann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0875-1592","authenticated-orcid":false,"given":"C.","family":"Sonigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"3809_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2025.0064","volume":"6","author":"M-O Quarmyne","year":"2025","unstructured":"Quarmyne M-O, Bock F, Lakshmanan S, Attell BK, Snyder A, Boudreaux J, et al. Newborn screening for sickle cell disease and thalassemia. JAMA Health Forum. 2025;6:e250064. https:\/\/doi.org\/10.1001\/jamahealthforum.2025.0064.","journal-title":"JAMA Health Forum"},{"key":"3809_CR2","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.3324\/haematol.2022.282098","volume":"108","author":"V Brousse","year":"2023","unstructured":"Brousse V, Bernaudin F, Melaine A, Goguillot M, Gallagher M, Benard S, et al. Severity and burden of sickle cell disease in France: a nationwide real-world study. Haematologica. 2023;108:2476\u201386. https:\/\/doi.org\/10.3324\/haematol.2022.282098.","journal-title":"Haematologica"},{"key":"3809_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100901","volume":"40","author":"J-B Arlet","year":"2024","unstructured":"Arlet J-B, Herquelot E, Lamarsalle L, Raguideau F, Bartolucci P. Impact of hospitalized vaso-occlusive crises in the previous calendar year on mortality and complications in adults with sickle cell disease: a French population-based study. Lancet Reg Health Eur. 2024;40:100901. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100901.","journal-title":"Lancet Reg Health Eur"},{"key":"3809_CR4","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/ajh.26286","volume":"96","author":"M de Montalembert","year":"2021","unstructured":"de Montalembert M, Voskaridou E, Oevermann L, Cannas G, Habibi A, Loko G, et al. Real-life experience with hydroxyurea in patients with sickle cell disease: results from the prospective ESCORT-HU cohort study. Am J Hematol. 2021;96:1223\u201331. https:\/\/doi.org\/10.1002\/ajh.26286.","journal-title":"Am J Hematol"},{"key":"3809_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ajh.26495","volume":"97","author":"BL Kroner","year":"2022","unstructured":"Kroner BL, Hankins JS, Pugh N, Kutlar A, King AA, Shah NR, et al. Pregnancy outcomes with hydroxyurea use in women with sickle cell disease. Am J Hematol. 2022;97:603\u201312. https:\/\/doi.org\/10.1002\/ajh.26495.","journal-title":"Am J Hematol"},{"key":"3809_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020597","volume":"11","author":"A Habibi","year":"2023","unstructured":"Habibi A, Cannas G, Bartolucci P, Voskaridou E, Joseph L, Bernit E, et al. Outcomes of pregnancy in sickle cell disease patients: results from the prospective ESCORT-HU cohort study. Biomedicines. 2023;11:597. https:\/\/doi.org\/10.3390\/biomedicines11020597.","journal-title":"Biomedicines"},{"key":"3809_CR7","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.4158\/EP13474.CR","volume":"20","author":"H Gharwan","year":"2014","unstructured":"Gharwan H, Neary NM, Link M, Hsieh MM, Fitzhugh CD, Sherins RJ, et al. Successful fertility restoration after allogeneic hematopoietic stem cell transplantation. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2014;20:e157-161. https:\/\/doi.org\/10.4158\/EP13474.CR.","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"3809_CR8","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.281.18.1701","volume":"281","author":"K Xu","year":"1999","unstructured":"Xu K, Shi ZM, Veeck LL, Hughes MR, Rosenwaks Z. First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia. JAMA. 1999;281:1701\u20136. https:\/\/doi.org\/10.1001\/jama.281.18.1701.","journal-title":"JAMA"},{"key":"3809_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/14647270903037751","volume":"12","author":"A Oyewo","year":"2009","unstructured":"Oyewo A, Salubi-Udu J, Khalaf Y, Braude P, Renwick P, Lashwood A, et al. Preimplantation genetic diagnosis for the prevention of sickle cell disease: current trends and barriers to uptake in a London teaching hospital. Hum Fertil. 2009;12:153\u20139. https:\/\/doi.org\/10.1080\/14647270903037751.","journal-title":"Hum Fertil"},{"key":"3809_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/bjh.16930","volume":"191","author":"S Vali","year":"2020","unstructured":"Vali S, Mukhtar S, Nandi A, Wilson K, Oakley L, El-Toukhy T, et al. Cumulative outcome of pre-implantation genetic diagnosis for sickle cell disease: a 5-year review. Br J Haematol. 2020;191:875\u20139. https:\/\/doi.org\/10.1111\/bjh.16930.","journal-title":"Br J Haematol"},{"key":"3809_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.rbmo.2020.01.025","volume":"40","author":"A Mayeur","year":"2020","unstructured":"Mayeur A, Ahdad N, Hesters L, Grynberg M, Romana S, Sonigo C, et al. Does the prognosis after PGT for structural rearrangement differ between female and male translocation carriers? Reprod Biomed Online. 2020;40:684\u201392. https:\/\/doi.org\/10.1016\/j.rbmo.2020.01.025.","journal-title":"Reprod Biomed Online"},{"key":"3809_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.rbmo.2023.02.010","volume":"47","author":"A Mayeur","year":"2023","unstructured":"Mayeur A, Benaloun E, Benguigui J, Duperier C, Hesters L, Chatzovoulou K, et al. Preimplantation genetic testing for mitochondrial DNA mutation: ovarian response to stimulation, outcomes and follow-up. Reprod Biomed Online. 2023;47:61\u20139. https:\/\/doi.org\/10.1016\/j.rbmo.2023.02.010.","journal-title":"Reprod Biomed Online"},{"key":"3809_CR13","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1093\/humrep\/deab214","volume":"36","author":"C Sonigo","year":"2021","unstructured":"Sonigo C, Mayeur A, Sadoun M, Pinto M, Benguigui J, Frydman N, et al. What is the threshold of mature oocytes to obtain at least one healthy transferable cleavage-stage embryo after preimplantation genetic testing for fragile X syndrome? Hum Reprod. 2021;36:3003\u201313. https:\/\/doi.org\/10.1093\/humrep\/deab214.","journal-title":"Hum Reprod"},{"key":"3809_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.rbmo.2017.10.113","volume":"36","author":"A Girardet","year":"2018","unstructured":"Girardet A, Ishmukhametova A, Viart V, Plaza S, Saguet F, Verriere G, et al. Thirteen years\u2019 experience of 893 PGD cycles for monogenic disorders in a publicly funded, nationally regulated regional hospital service. Reprod Biomed Online. 2018;36:154\u201363. https:\/\/doi.org\/10.1016\/j.rbmo.2017.10.113.","journal-title":"Reprod Biomed Online"},{"key":"3809_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10815-024-03324-1","volume":"42","author":"C Sonigo","year":"2025","unstructured":"Sonigo C, Ranisavljevic N, Guigui M, Anahory T, Mayeur A, Moutou C, et al. Ovarian response in preimplantation genetic testing for myotonic dystrophy type 1. J Assist Reprod Genet. 2025;42:185\u201392. https:\/\/doi.org\/10.1007\/s10815-024-03324-1.","journal-title":"J Assist Reprod Genet"},{"key":"3809_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.xfre.2023.06.001","volume":"4","author":"JC Combs","year":"2023","unstructured":"Combs JC, Dougherty M, Yamasaki MU, DeCherney AH, Devine KM, Hill MJ, et al. Preimplantation genetic testing for sickle cell disease: a cost-effectiveness analysis. FS Rep. 2023;4:300\u20137. https:\/\/doi.org\/10.1016\/j.xfre.2023.06.001.","journal-title":"FS Rep"},{"key":"3809_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27102","volume":"65","author":"I Darbari","year":"2018","unstructured":"Darbari I, O\u2019Brien JE, Hardy SJ, Speller-Brown B, Thaniel L, Martin B, et al. Views of parents of children with sickle cell disease on pre-implantation genetic diagnosis. Pediatr Blood Cancer. 2018;65:e27102. https:\/\/doi.org\/10.1002\/pbc.27102.","journal-title":"Pediatr Blood Cancer"},{"key":"3809_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jpeds.2020.04.027","volume":"223","author":"M Attia","year":"2020","unstructured":"Attia M, Kripalani S, Darbari I, Nickel RS. Parents of children with sickle cell disease are interested in preimplantation genetic testing. J Pediatr. 2020;223:178-182.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2020.04.027.","journal-title":"J Pediatr"},{"key":"3809_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10815-021-02358-z","volume":"39","author":"ML Early","year":"2022","unstructured":"Early ML, Strodel RJ, Lake IV, Ruddy JA, Saba JA, Singh SM, et al. Acceptable, hopeful, and useful: development and mixed-method evaluation of an educational tool about reproductive options for people with sickle cell disease or trait. J Assist Reprod Genet. 2022;39:183\u201393. https:\/\/doi.org\/10.1007\/s10815-021-02358-z.","journal-title":"J Assist Reprod Genet"},{"key":"3809_CR20","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s10815-020-01837-z","volume":"37","author":"ML Early","year":"2020","unstructured":"Early ML, Kumar P, Marcell AV, Lawson C, Christianson M, Pecker LH. Literacy assessment of preimplantation genetic patient education materials exceed national reading levels. J Assist Reprod Genet. 2020;37:1913\u201322. https:\/\/doi.org\/10.1007\/s10815-020-01837-z.","journal-title":"J Assist Reprod Genet"},{"key":"3809_CR21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.fertnstert.2021.12.030","volume":"117","author":"Ethics Committee of the American Society for Reproductive Medicine","year":"2022","unstructured":"Ethics Committee of the American Society for Reproductive Medicine. Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an ethics committee opinion. Fertil Steril. 2022;117:713\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.12.030.","journal-title":"Fertil Steril"},{"key":"3809_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5935\/1518-0557.20180017","volume":"22","author":"CD Martinhago","year":"2018","unstructured":"Martinhago CD, Endo KR, Oliveira MA, Dias AM, Pereira GS, Azzolini AM, et al. The first South American case of pre-implantation genetic diagnosis to select compatible embryo for cord blood transplantation as treatment for sickle cell anemia. JBRA Assist Reprod. 2018;22:71\u20134. https:\/\/doi.org\/10.5935\/1518-0557.20180017.","journal-title":"JBRA Assist Reprod"},{"key":"3809_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bpobgyn.2011.10.001","volume":"26","author":"J Howard","year":"2012","unstructured":"Howard J, Oteng-Ntim E. The obstetric management of sickle cell disease. Best Pract Res Clin Obstet Gynaecol. 2012;26:25\u201336. https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.10.001.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"3809_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213024","volume":"14","author":"J Kopeika","year":"2019","unstructured":"Kopeika J, Oyewo A, Punnialingam S, Reddy N, Khalaf Y, Howard J, et al. Ovarian reserve in women with sickle cell disease. PLoS One. 2019;14(2):e0213024. https:\/\/doi.org\/10.1371\/journal.pone.0213024.","journal-title":"PLoS One"},{"issue":"3","key":"3809_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00353-2","volume":"10","author":"LH Pecker","year":"2023","unstructured":"Pecker LH, Oteng-Ntim E, Nero A, Lanzkron S, Christianson MS, Woolford T, et al. Expecting more: the case for incorporating fertility services into comprehensive sickle cell disease care. Lancet Haematol. 2023;10(3):e225. https:\/\/doi.org\/10.1016\/S2352-3026(22)00353-2.","journal-title":"Lancet Haematol"},{"key":"3809_CR26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.fertnstert.2018.05.016","volume":"110","author":"LH Pecker","year":"2018","unstructured":"Pecker LH, Maher JY, Law JY, Beach MC, Lanzkron S, Christianson MS. Risks associated with fertility preservation for women with sickle cell anemia. Fertil Steril. 2018;110:720\u201331. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.05.016.","journal-title":"Fertil Steril"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-026-03809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-026-03809-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-026-03809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T09:56:58Z","timestamp":1776851818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-026-03809-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["3809"],"URL":"https:\/\/doi.org\/10.1007\/s10815-026-03809-1","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"These projects are part of \u201cresearch not involving the human person\u201d (RNIPH Recherche n\u2019impliquant pas la personne humaine), research framed at the legislative level by the regulations on data protection. In France, this type of work can be carried out without the advice and\/or the approval of an ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}